Neural Therapeutics Inc. (CSE:NURL)
Canada
· Delayed Price · Currency is CAD 0.0250
+0.0050 (25.00%)
At close: Dec 5, 2025
Neural Therapeutics Statistics
Total Valuation
CSE:NURL has a market cap or net worth of CAD 4.22 million. The enterprise value is 4.80 million.
| Market Cap | 4.22M |
| Enterprise Value | 4.80M |
Important Dates
The last earnings date was Friday, November 21, 2025.
| Earnings Date | Nov 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:NURL has 168.70 million shares outstanding. The number of shares has increased by 19.37% in one year.
| Current Share Class | 168.70M |
| Shares Outstanding | 168.70M |
| Shares Change (YoY) | +19.37% |
| Shares Change (QoQ) | +12.14% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 7.16% |
| Float | 167.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -5.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.67 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.10
| Current Ratio | 1.10 |
| Quick Ratio | 0.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -422.30% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -5,824.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.14 |
| Average Volume (20 Days) | 272,964 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -972,264 |
| Pretax Income | -1.03M |
| Net Income | -1.03M |
| EBITDA | n/a |
| EBIT | -972,264 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 165,376 in cash and 744,670 in debt, giving a net cash position of -579,294 or -0.00 per share.
| Cash & Cash Equivalents | 165,376 |
| Total Debt | 744,670 |
| Net Cash | -579,294 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -727,976 |
| Book Value Per Share | -0.01 |
| Working Capital | 16,694 |
Cash Flow
| Operating Cash Flow | -315,342 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:NURL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.37% |
| Shareholder Yield | -19.37% |
| Earnings Yield | -24.33% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |